Amphastar Pharmaceuticals (AMPH) Net Cash Flow Growth (1y) (2014 - 2026)
Amphastar Pharmaceuticals (AMPH) Net Cash Flow Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -117.27% |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | -167.84% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -290.21% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 270.63% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -367.42% |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | -7.60% |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 272.00% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 934.64 Mn | 644.51 Mn | 93.47 Mn | 1,005.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,005.12% |
| Mar 31, 2026 | -97.10% |
| Dec 31, 2025 | -13.79% |
| Sep 30, 2025 | 1,017.85% |
| Jun 30, 2025 | 141.40% |
| Mar 31, 2025 | -45.47% |
| Dec 31, 2024 | 67.93% |
| Sep 30, 2024 | -97.86% |
| Jun 30, 2024 | 54.95% |
| Mar 31, 2024 | 177.79% |
| Dec 31, 2023 | -10,738.45% |
| Sep 30, 2023 | 1,459.14% |
| Jun 30, 2023 | -301.76% |
| Mar 31, 2023 | -55.72% |
| Dec 31, 2022 | -105.89% |
| Sep 30, 2022 | 50.18% |
| Jun 30, 2022 | -128.00% |
| Mar 31, 2022 | 518.12% |
| Dec 31, 2021 | 340.78% |
| Sep 30, 2021 | -5,461.21% |